(Q34452681)

2 August 2017

1 reference

title

Delivery of novel macromolecular drugs against HIV-1. (English)

1 reference

2 August 2017

1 reference

Düzgünes N

1

1 reference

2 August 2017

Simões S

2

1 reference

2 August 2017

Konopka K

3

1 reference

2 August 2017

Rossi JJ

4

1 reference

2 August 2017

Pedroso de Lima MC

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

949-970

1 reference

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

HIV disease treatment in the era of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antiretroviral therapy: 'the state of the art'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Targeting the HIV-protease in AIDS therapy: a current clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

New developments in the biology and treatment of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antisense technology and prospects for therapy of viral infections and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The delivery of antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Delivery systems for antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Surrogate cells or Trojan horses. The discovery of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Inhibition of human immunodeficiency virus type 1-mediated cytopathic effects by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Fate of cationic liposomes and their complex with oligonucleotide in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Inhibition of HIV replication by immunoliposomal antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

New concepts in the immunopathogenesis of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The role of CpG motifs in immunostimulation and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozyme therapy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The biochemistry of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Therapeutic applications of ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

A hammerhead ribozyme targeted to the human chemokine receptor CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozymes as human therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Cationic liposome-mediated RNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The potential use of catalytic RNAs in therapy of HIV infection and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Expression of ribozymes in gene transfer systems to modulate target RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Expression of small, therapeutic RNAs in human cell nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Gene therapy using adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Biological barriers to cellular delivery of lipid-based DNA carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Efficient gene transfer by transferrin lipoplexes in the presence of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Systemic gene expression after intravenous DNA delivery into adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Human gene therapy comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Assessment of recombinant adenoviral vectors for hepatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Gene therapy using SV40-derived vectors: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Viral vectors for gene transfer: a review of their use in the treatment of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Progress with retroviral gene vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Design and application of HSV vectors for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Viral vectors for gene delivery and gene therapy within the endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Chromatin domain boundaries in the Bithorax complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

An enhancer-blocking element between alpha and delta gene segments within the human T cell receptor alpha/delta locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Stem cell gene therapy, position effects and chromatin insulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Characterization of the chicken beta-globin insulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

SARs stimulate but do not confer position independent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Regulation of Thy-1 gene expression by the methylation of the 5' region of Thy-1 gene and intracellular regulatory factors in immature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

A DNA signal from the Thy-1 gene defines de novo methylation patterns in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Pre-mRNA processing factors are required for nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Antisense oligonucleotide therapeutics: drug delivery and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.949

Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/J.1460-2075.1994.TB06787.X

Identifiers

DOI

10.1517/14712598.1.6.949

1 reference

2 August 2017

1 reference